Nanox.AI Expands UK Reach and Optimizes AI for Intel Processors

Nano-X Imaging Ltd. (NASDAQ: NNOX) (“Nanox”) is making strategic moves to expand the use of artificial intelligence in medical imaging through two key initiatives. First, the company has entered into an exclusive three-year reseller agreement with Vertec Scientific, which includes minimum annual license commitments. This partnership establishes a dedicated distribution channel in the United Kingdom for HealthOST, Nanox.AI’s software solution that provides qualitative and quantitative analysis of spinal CT images to assist clinicians in evaluating spinal musculoskeletal diseases, including osteoporosis. By leveraging Vertec Scientific’s established presence, Nanox aims to accelerate adoption of its AI-powered tools in the UK healthcare market.

Second, Nanox.AI has optimized its imaging AI framework for Intel Core Ultra processors using OpenVINO, a toolkit that enables efficient AI inference on local hardware. This optimization demonstrates the potential to run AI algorithms directly on hospital hardware, reducing reliance on cloud connectivity. This is particularly important for healthcare providers with limited internet infrastructure or those concerned about data privacy and latency. By enabling on-premises AI processing, Nanox offers more flexible deployment options and could make its solutions more attractive to a broader range of medical facilities. Together, these developments support Nanox’s overarching strategy of extracting additional clinical value from already performed scans while expanding commercial reach and offering healthcare providers more flexible deployment options.

Nanox is dedicated to driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The Nanox ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs of chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery. For more information, please visit www.Nanox.vision.